Results 11 to 20 of about 168,114 (189)

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG Positive Patient [PDF]

Case Reports in Neurological Medicine, 2018
Background. A serum immunoglobulin G (IgG) autoantibody specific for the myelin oligodendrocyte glycoprotein (MOG) is detected in the subgroup patients with inflammatory demyelinating diseases of the central nervous system (CNS). However, whether MOG-IgG
Sayed Hamid Mohseni, Hanne Pernille Bro Skejoe, Jens Wuerfel, Friedemann Paul, Markus Reindl, Nasrin Asgari   +5 more
doaj   +6 more sources

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study. [PDF]

PLoS ONE, 2017
Optic neuritis (ON) in patients with anti-myelin oligodendrocyte glycoprotein (MOG)-IgG antibodies has been associated with a better clinical outcome than anti-aquaporin 4 (AQP4)- IgG ON. Average retinal nerve fiber layer thickness (RNFL) correlates with
Hadas Stiebel-Kalish, Itay Lotan, Judith Brody, Gabriel Chodick, Omer Bialer, Romain Marignier, Michael Bach, Mark Andrew Hellmann   +7 more
doaj   +2 more sources

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study [PDF]

Frontiers in Neurology, 2020
Aims: To explore differences in advanced brain magnetic resonance imaging (MRI) characteristics between myelin oligodendrocyte (MOG) immunoglobulin (IgG) and aquaporin-4 (AQP4) IgG seropositive (+) neuromyelitis optica spectrum disorders (NMOSD).Methods:
Felix A. Schmidt, Felix A. Schmidt, Felix A. Schmidt, Felix A. Schmidt, Claudia Chien, Joseph Kuchling, Joseph Kuchling, Judith Bellmann-Strobl, Judith Bellmann-Strobl, Klemens Ruprecht, Klemens Ruprecht, Nadja Siebert, Nadja Siebert, Susanna Asseyer, Susanna Asseyer, Sven Jarius, Alexander U. Brandt, Alexander U. Brandt, Alexander U. Brandt, Michael Scheel, Michael Scheel, Michael Scheel, Friedemann Paul, Friedemann Paul, Friedemann Paul   +24 more
doaj   +2 more sources

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders [PDF]

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2018
Background Pain is a frequent symptom in aquaporin-4-immunoglobulin-G-positive neuromyelitis optica spectrum disorders (AQP4-IgG-pos. NMOSD). Data on pain in myelin-oligodendrocyte-glycoprotein-immunoglobulin-G autoimmunity with a clinical NMOSD ...
Susanna Asseyer, Felix Schmidt, Claudia Chien, Michael Scheel, Klemens Ruprecht, Judith Bellmann-Strobl, Alexander U Brandt, Friedemann Paul   +7 more
doaj   +2 more sources

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients [PDF]

Multiple Sclerosis and Related Disorders, 2020
To assess the effect of anti-CD20 B-cell depletion with rituximab (RTX) on relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD).Retrospective review of RTX-treated MOGAD patients from 29 centres in 13 countries. The primary outcome measure was change in relapse rate after starting rituximab (Poisson regression model)
Brian Weinshenker, David Laplaud
exaly   +8 more sources

Case report: MOG-IgG-associated encephalitis with Epstein-Barr virus infection and Alzheimer's pathologic change in cerebrospinal fluid [PDF]

Frontiers in Neurology, 2022
Immunoglobulin G antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) associated disease is a rare, demyelinated disease in the central nerve system (CNS) predominately involving optic nerve, spinal cord, and brain leading to optic neuritis (ON ...
Lin Li, Chuan Li, Dan Yao, Yun-feng Hao, Chao Zhao, Qi Yan, Jun-tong Liu, Jun-tong Liu, Shu-yu Liu, Shu-yu Liu, Wen-ping Zhu, Wen-ping Zhu, Ying Du, Wei Zhang   +13 more
doaj   +2 more sources

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria. [PDF]

Mult Scler, 2022
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is now recognized as distinct from multiple sclerosis (MS). Objective: To evaluate the importance of considering myelin oligodendrocyte glycoprotein ...
Fadda G, Waters P, Woodhall M, Brown RA, O'Mahony J, Castro DA, Longoni G, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A.   +11 more
europepmc   +3 more sources

AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis

Frontiers in Neurology, 2020
Background: Optic neuritis (ON) is a cardinal manifestation of multiple sclerosis (MS), aquaporin-4 (AQP4)-IgG-, and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated disease.
Shiv Saidha, Loulwah Mukharesh, Peter A Calabresi   +2 more
exaly   +3 more sources

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method [PDF]

Frontiers in Neurology, 2021
Background and purpose: Immunoadsorption (IA) is an antibody-depleting therapy used to treat neuromyelitis optica spectrum disorder (NMOSD) associated to antiaquaporin 4 (anti-AQP4-IgG) and antimyelin oligodendrocyte glycoprotein (anti-MOG-IgG) serum ...
Luca Bollo, Pietro Iaffaldano, Maddalena Ruggieri, Claudia Palazzo, Mariangela Mastrapasqua, Alessia Manni, Damiano Paolicelli, Antonio Frigeri, Maria Trojano   +8 more
doaj   +2 more sources

Case of MOG-IgG-associated disease with ankylosing spondylitis: A rare coexistence. [PDF]

Turk J Phys Med Rehabil, 2023
Myelin oligodendrocyte glycoprotein-associated disease (MOGAD) is an inflammatory neurological disease. It progresses with attacks by affecting the optic nerves and spinal cord. Bilateral or recurrent optic neuritis are the most common findings in adult patients.
Türk SM, Kotan D, Gönüllü E, Öztürk Z, Karataş D.   +4 more
europepmc   +3 more sources